肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2013年
4期
227-229,233
,共4页
王逸君%王颖杰%常冬姝%李宏奇%李平%王济东%吴伟章%康晓黎%邵银剑
王逸君%王穎傑%常鼕姝%李宏奇%李平%王濟東%吳偉章%康曉黎%邵銀劍
왕일군%왕영걸%상동주%리굉기%리평%왕제동%오위장%강효려%소은검
肺%肿瘤转移%γ射线%囊腺癌%放射疗法
肺%腫瘤轉移%γ射線%囊腺癌%放射療法
폐%종류전이%γ사선%낭선암%방사요법
Pulmonary%Neoplasm metastases%Gamma rays%Cystadenocarcinoma%Radiotherapy
目的 观察体部伽玛刀治疗头颈部腺样囊性癌多发肺转移瘤的临床疗效.方法 对15例头颈部腺样囊性癌肺转移瘤患者共计137个病灶采用立体定向体部伽玛刀治疗.单次治疗病灶2~10灶,中位数5灶.以50%剂量线为处方剂量线,单次照射剂量3~5 Gy,中位数4Gy,1次/d,5次/周,10~16次.肿瘤边缘总剂量30~52 Gv,中位数40 Gy.结果 137个病灶中,完全缓解58灶(42.3%),部分缓解64灶(46.7%),稳定15灶(10.9%),进展0灶,总有效率为89.1%.治疗后1、2、3年局控率均为100.0%.治疗后1、2、3、4、5年生存率分别为100.0%、100.0%、90.9%、63.6%、31.8%.结论 体部伽玛刀治疗头颈部腺样囊腺癌多发肺转移瘤疗效较好,反应轻微,是一种安全有效的治疗手段.
目的 觀察體部伽瑪刀治療頭頸部腺樣囊性癌多髮肺轉移瘤的臨床療效.方法 對15例頭頸部腺樣囊性癌肺轉移瘤患者共計137箇病竈採用立體定嚮體部伽瑪刀治療.單次治療病竈2~10竈,中位數5竈.以50%劑量線為處方劑量線,單次照射劑量3~5 Gy,中位數4Gy,1次/d,5次/週,10~16次.腫瘤邊緣總劑量30~52 Gv,中位數40 Gy.結果 137箇病竈中,完全緩解58竈(42.3%),部分緩解64竈(46.7%),穩定15竈(10.9%),進展0竈,總有效率為89.1%.治療後1、2、3年跼控率均為100.0%.治療後1、2、3、4、5年生存率分彆為100.0%、100.0%、90.9%、63.6%、31.8%.結論 體部伽瑪刀治療頭頸部腺樣囊腺癌多髮肺轉移瘤療效較好,反應輕微,是一種安全有效的治療手段.
목적 관찰체부가마도치료두경부선양낭성암다발폐전이류적림상료효.방법 대15례두경부선양낭성암폐전이류환자공계137개병조채용입체정향체부가마도치료.단차치료병조2~10조,중위수5조.이50%제량선위처방제량선,단차조사제량3~5 Gy,중위수4Gy,1차/d,5차/주,10~16차.종류변연총제량30~52 Gv,중위수40 Gy.결과 137개병조중,완전완해58조(42.3%),부분완해64조(46.7%),은정15조(10.9%),진전0조,총유효솔위89.1%.치료후1、2、3년국공솔균위100.0%.치료후1、2、3、4、5년생존솔분별위100.0%、100.0%、90.9%、63.6%、31.8%.결론 체부가마도치료두경부선양낭선암다발폐전이류료효교호,반응경미,시일충안전유효적치료수단.
Objective To evaluate the value of the stereotactic gamma-ray body radiation therapy for patients with pulmonary metastases derived from adenoid cystic carcinoma of the head and neck.Methods 15 patients with 137 lung metastases treated with stereotactic gamma-ray body radiation therapy were analyzed.The patients experienced one to five courses of stereotactic gamma-ray body radiation therapy.2 to 10 lesions were radiated in one treatment and the median number is 5.The daily radiation dose of 50 %isodose line covering metastatic lesions was from 3-5 Gy and 5 fractions per week.30-52 Gy total doses in the edge of 50 % isodose line were divided into 10-16 times.Results 58 (42.34 %) lesions completely disappeared,64 (46.72 %) lesions were assessed into partial responses,15 (10.94 %) stable disease and 0 progression disease.The total effective rate was 89.06 %.Local control rates of 1,3 and 5-year were all 100 %.The overall survival rates of 1 year,2-year,3-year,4-year and 5-year were 100 %,100 %,90.9 %,63.6 % and 31.8 %,respectively.Conclusion The stereotactic gamma-ray body radiation therapy is an effective and safe method in treatment with lung metastases from primary adenoid cystic adenocarcinoma of head and neck.